Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey

BMC Public Health201010:569

DOI: 10.1186/1471-2458-10-569

Received: 17 May 2010

Accepted: 22 September 2010

Published: 22 September 2010

Abstract

Background

Cardiovascular disease (CVD) is the leading cause of death among older people in Africa. This study aimed to investigate the relationship of urbanization and ethnicity with CVD risk markers in Kenya.

Methods

A cross-sectional population-based survey was carried out in Nakuru Kenya in 2007-2008. 100 clusters of 50 people aged ≥50 years were selected by probability proportionate to size sampling. Households within clusters were selected through compact segment sampling. Participants were interviewed by nurses to collect socio-demographic and lifestyle information. Nurses measured blood pressure, height, weight and waist and hip circumference. A random finger-prick blood sample was taken to measure glucose and cholesterol levels.

Hypertension was defined as systolic blood pressure (SBP) ≥140 mm Hg, or diastolic blood pressure (DBP) ≥90 mm Hg or current use of antihypertensive medication; Diabetes as reported current medication or diet control for diabetes or random blood glucose level ≥11.1 mmol/L; High cholesterol as random blood cholesterol level ≥5.2 mmol/L; and Obesity as Body Mass Index (BMI)≥30 kg/m2.

Results

5010 eligible subjects were selected, of whom 4396 (88%) were examined. There was a high prevalence of hypertension (50.1%, 47.5-52.6%), obesity (13.0%, 11.7-14.5%), diabetes (6.6%, 5.6-7.7%) and high cholesterol (21.1%, 18.6-23.9). Hypertension, diabetes and obesity were more common in urban compared to rural groups and the elevated prevalence generally persisted after adjustment for socio-demographic, lifestyle, obesity and cardiovascular risk markers. There was also a higher prevalence of hypertension, obesity, diabetes and high cholesterol among Kikuyus compared to Kalenjins, even after multivariate adjustment. CVD risk markers were clustered both across the district and within individuals. Few people received treatment for hypertension (15%), while the majority of cases with diabetes received treatment (68%).

Conclusions

CVD risk markers are common in Kenya, particularly in urban areas. Exploring differences in CVD risk markers between ethnic groups may help to elucidate the epidemiology of these conditions.

Background

Infectious diseases are still the principal cause of death in Africa [1]. However, among older people coronary heart disease (CHD) and stroke are emerging as the leading cause, responsible for more than a quarter of deaths in people 60 years and over in Africa [2, 3]. This represents a dramatic shift as CHD was virtually unknown in Africa until recently [4, 5]. Stroke is particularly common in Africa in comparison to CHD [6], and stroke mortality rates and prevalence of disabling stroke in most African countries are comparable to levels seen in high-income countries [79]. African countries are therefore experiencing a shift in the epidemiological transition [10], while retaining a high burden of infectious diseases.

The rise in cardiovascular disease (CVD) is linked to the increase in hypertension, diabetes, obesity, and high cholesterol observed in Africa in recent years. Obesity [1114] and hypertension [11, 1517] are now common throughout Africa, particularly in urban areas [11, 12, 14, 16, 17]. The number of people with diabetes in Sub-Saharan Africa is expected to more than double between 2000 and 2030 [18], and diabetes is particularly common in urban areas [19]. Urbanisation is therefore a key feature in the rise of CVD. Currently 40% of Africans live in urban areas [20], and it is estimated that by 2030 half of Africans will live in urban areas. The Kenyan Luo Migration Study elegantly demonstrated the impact of rural-urban migration on CVD risk in Africa [21]. Rural migrants to Nairobi experienced a rise in systolic and diastolic blood pressure after only one month of migration. In contrast, the effect of rural-urban migration on blood pressure was not observed in a recent study in Tanzania, even though physical activity levels fell and weight increased after migration [22]. The discrepancy between the two studies may be because the rural-urban contrast in sodium intake was smaller in the Tanzanian compared to the Kenyan study (personal communication). The impact of rural-urban migration on health may therefore vary depending on setting.

People of African origin may be particularly vulnerable to hypertension. The prevalence of hypertension is high among people of African origin compared to Whites independent of BMI [2325], and there is a younger age at onset in Africa [15] and among people of African descent [26]. Although the same risk markers are largely responsible for myocardial infarction (MI) across the globe [27], hypertension was associated with a higher MI risk in the Black African group than in the overall INTERHEART group [28]. There may also be greater difficulty in achieving control [26], and more aggressive presentation [26, 29] and progress [28] of hypertension among people of African origin. This vulnerability may be due to lifestyle factors, but may also be influenced by ethnicity which varies widely within Africa and is linked to substantial heterogeneity in body composition [14], which may exert important metabolic effects [30].

The aim of this study was to investigate the relationship of urbanization and ethnicity with the prevalence of obesity, hypertension, diabetes and high cholesterol in a study of elderly people in Nakuru district, Kenya.

Methods

Settings and population

Nakuru district has a population of 1.2 million, one third of which is urban. Nakuru is broadly representative of Kenya in terms of ethnic diversity and economic activities. The two dominant ethnic groups are Kikuyus and Kalenjins. The Kikuyu are related to other Bantu-speaking peoples of East Africa while Kalenjins are of Nilotic origin.

During Jan 2007- Dec 2008, a sample of 100 clusters of 50 people aged ≥50 years were selected across Nakuru district through probability proportionate to size sampling, using the electoral role as the sampling frame. Clusters were classed as "rural" or "urban" using the classification of the district statistical office. Households were selected within clusters through modified compact segment sampling [31]. The village leaders produced a sketch map of the polling area. The polling area was divided into segments each including approximately 50 people aged ≥ 50 years. One segment was chosen at random by drawing lots and all households in the segment were included in the sample sequentially, until 50 people aged ≥50 years were identified. If the segment did not include 50 people aged ≥50 years then another segment was chosen at random and sampling continued.

The enumeration team visited households, assisted by a village guide, and invited all eligible participants aged ≥50 years to the examination clinic which would be held at a convenient place in the cluster over the subsequent two days. Eligible participants were defined as those aged ≥50 years resident in the cluster (i.e. living there at least 6 months per year) who had slept in the house either the night before or were planning on sleeping in the house that night. If an eligible person was absent then the survey team revisited the household at least two times.

Examination clinic

Interviews

Participants were interviewed by trained nurses. Information was collected on demographic data, education and assets (building materials of the house - type of walls, roof, floor and toilet; ownership of household assets - radio, TV, fridge, phone, cupboard, sofa set, sewing machine, table, bicycle and vehicle; animal ownership - cows, sheep/goats). People were asked whether their mother tongue was "Kikuyu", "Kalenjin" or other. For simplicity, people will be classified as "Kikuyu" and "Kalenjin" in the text. Information was also collected on health behaviour (smoking, alcohol use) and health status (diagnosis of diabetes or hypertension, family history and their treatment).

Physical examination

A nurse recorded the blood pressure of participants three times on the right arm of the participant, at least five minutes apart after an initial period of five minutes of rest using the Omron digital automatic monitor (model HEM907). A medium cuff size was used (to fit arms 22 to 32 cm). The average of the last two readings was used as the measures of systolic and diastolic blood pressure (to nearest 1 mm Hg). A random finger-prick blood sample was taken to measure glucose (Accutrend GC system) and cholesterol levels (Accutrend GC system). The technical data from the company asserts that precision is <3% for glucose and <5% for cholesterol [32]. Weight was measured to the nearest kg using standard scales to the nearest 0.1 kg (Seca 761 scales) after the participant had removed all heavy clothing and shoes. Height was measured to the nearest cm while the participant stood without shoes using a standardized stadiometer (Leicester Height Measure). For weight and height the average of two readings was recorded. Waist and hip circumferences were measured with a tape. The waist circumference was measured at umbilicus level in mid-expiration to the nearest 0.1 cm. The hip circumference was measured at the point of largest gluteal circumference to the nearest 0.1 cm.

Training

The examination team received three weeks of training. Inter observer variation (IOV) was assessed during the training weeks at the Nakuru Provincial General Hospital. IOV on anthropometric variables were done by repeat measuring of 50 subjects by the two nurses. The level of agreement required was to the nearest 1 cm for circumferences and height, and to the nearest 0.5 kg for weight. The staff were retrained or replaced if IOV scores indicated poor comparability (kappa < 0.5).

Statistical analysis

Statistical analyses were undertaken using the SAS statistical package (version 9.2). The four CVD risk markers considered were hypertension, diabetes, high cholesterol and obesity. Hypertension was defined as systolic blood pressure (SBP) was ≥140 mm Hg, or diastolic blood pressure (DBP) ≥90 mm Hg or current use of antihypertensive medication [33]. Diabetes was defined as reported current medication (tablets or insulin) or diet control for diabetes or random blood glucose level ≥11.1 mmol/L [34]. People were categorized as having high cholesterol if their random blood cholesterol level was ≥5.2 mmol/L [35]. Obesity was defined as Body Mass Index (BMI)≥30 kg/m2 [36]. Prevalence estimates for the four CVD risk markers were calculated taking account of the design effect (DEFF) in estimating the confidence intervals. The DEFF was not taken into account for other analyses. A relative index of socio-economic status (SES) was calculated based on building materials of the house, ownership of ten household assets and education status using principal components analysis [37]. The derived index was divided into quartiles from poorest to least poor.

We assessed the association between rural-urban status and, in turn, hypertension, diabetes, high cholesterol and obesity through logistic regression models. The models were adjusted in turn for, a) for age (50-59, 60-69, 70-79, ≥80) and sex, b) age, sex and socio-demographic factors (SES score in quartiles), c) age, sex, BMI (<20, 20-25, >25-30, ≥30), waist hip ratio (WHR - in quartiles), smoking (current, former, never) and alcohol (current, former, never), d) age, sex, diabetes and high cholesterol (as appropriate) and e) fully adjusted model. These models were repeated assessing the association between the four CVD markers and Kikuyu or Kalenjin ethnicity, adjusting for urban status in models b and e. We included an interaction factor in the logistic regression models for ethnicity to assess whether there was an interaction between ethnicity and urban status in the relationship with CVD risk markers. We assessed the proportion of people receiving medical treatment among people who were defined as "hypertensive", and attempted to identify predictors of treatment status through logistic regression models. This was repeated for people with diabetes.

We assessed whether the CVD risk markers were clustered geographically by calculating the DEFF for each of the variables. We assessed whether there was clustering of the CVD risk markers within individuals. To do this, we derived expected frequencies of co-occurrence of risk markers (hypertension, diabetes, high cholesterol and obesity) from none through to four risk markers by combining probabilities, assuming a binomial distribution and independence between them [38]. We estimated observed to expected ratios for all participants and then separately for urban and rural groups and for Kikuyu and Kalenjin groups. We considered that there was clustering if the observed:expected ratios were high for no risk markers, low for one risk marker and high for three or more risk markers. We calculated chi-square statistics with 3 degrees of freedom to test the significance of the overall distribution of expected and observed counts within each group.

Ethical approval

Ethical approval for this work was granted by the London School of Hygiene & Tropical Medicine and The Kenya Medical Research Institute Ethical Committee and Nakuru District Health Management Team. Informed consent was obtained from the subjects. All people with other treatable conditions were referred for appropriate treatment.

Results

We examined 4,396 (88%) of the 5,010 people invited. Among those examined 1,437 (33%) lived in urban and 2,959 (67%) in rural areas (Table 1). Urban dwellers were younger, and had higher education levels and asset scores than rural dwellers. They were also more likely to be smokers and obese, than rural participants. Kikuyus made up 63% of the sample and Kalenjins 23% while the remaining 15% consisted of other language speakers. Kikuyus were more likely than Kalenjins to live in urban areas or to be female, and they had higher levels of education and higher SES scores. Kikuyus were less likely to be current smokers or consumers of alcohol. Kikuyus were significantly shorter yet heavier than Kalenjins among both men (166 cm vs 168 cm, 64 kg vs 60 kg) and women (156 cm vs 158 cm, 62 kg vs 58 kg) and consequently had higher BMIs.
Table 1

Demographic characteristics and health behavior comparing urban and rural participants, and Kikuyus and Kalenjins

 

Urban (n = 1437)

Rural (n = 2959)

Age and sex adjusted OR (95% CI)

Kikuyu (n = 2760)

Kalenjin (n = 1015)

Age and sex adjusted OR (95% CI)

Age

      

50-59

57%

38%

Baseline

40%

40%

Baseline

60-69

26%

31%

0.6 (0.5-0.7)

32%

28%

1.2 (1.0-1.4)

70-79

11%

20%

0.4 (0.3-0.5)

17%

20%

0.9 (0.7-1.1)

≥80

6%

11%

0.4 (0.3-0.5)

10%

11%

0.9 (0.7-1.2)

Sex

      

Men

49%

47%

Baseline

44%

53%

Baseline

Women

51%

53%

0.9 (0.8-1.0)

56%

47%

1.4 (1.2-1.6)

Language

      

Kikuyu

65%

62%

Baseline

   

Kalenjin

6%

31%

0.2 (0.1-0.2)

   

Other

29%

7%

3.3 (2.7-4.0)

   

Urban

   

931 (34%)

84 (8%)

Baseline

Rural

   

1812 (66%)

924 (92%)

5.7 (4.5-7.2)

Education

      

Any

79%

61%

1.4 (1.3-1.6)

71%

51%

1.9 (1.7-2.1)

None

21%

39%

Baseline

29%

49%

Baseline

SES score

      

1 (poorest)

8%

33%

Baseline

20%

44%

Baseline

2

14%

31%

1.6 (1.2-2.0)

26%

27%

2.4 (2.0-2.9)

3

24%

26%

3.1 (2.5-3.9)

27%

20%

3.4 (2.8-4.2)

4 (richest)

54%

11%

16.7 (13.3-21.1)

26%

9%

7.8 (6.0-10.2)

Smoking

      

Never

70%

70%

Baseline

69%

73%

Baseline

Current

7%

8%

1.4 (1.1-1.8)

8%

6%

0.5 (0.3-0.6)

Former

23%

22%

1.1 (0.9-1.3)

24%

20%

2.0 (1.6-2.5)

Alcohol

      

Never

41%

38%

Baseline

45%

23%

Baseline

Former

41%

46%

0.9 (0.7-1.0)

44%

49%

0.4 (0.3-0.5)

Current

18%

17%

0.9 (0.7-1.1)

11%

28%

0.2 (0.1-0.2)

BMI cat

      

Underweight

8%

17%

0.7 (0.5-0.9)

12%

21%

0.7 (0.6-0.9)

Normal

41%

54%

Baseline

48%

56%

Baseline

Overweight

30%

19%

2.1 (1.7-2.4)

25%

15%

1.9 (1.5-2.3)

Obese

20%

10%

2.8 (2.3-3.5)

14%

8%

2.0 (1.5-2.6)

There was a high prevalence of hypertension (50.1%, 47.5-52.6%), obesity (13.0%, 11.7-14.5%), diabetes (6.6%, 5.6-7.7%) and high cholesterol (21.1%, 18.6-23.9%). Mean SBP and DBP were higher in urban than rural areas among both men and women (Table 2). Similarly, mean glucose and cholesterol levels and markers of obesity were higher in urban than rural men and this pattern was generally repeated among women. The prevalence of obesity generally fell sharply with age (Figure 1). The prevalence of hypertension increased steadily with age, and was consistently higher in urban than rural areas (Figure 2). The association between prevalence and age were less clear for the diabetes (Figure 3) and high cholesterol (data not shown). Meanwhile, SBP increased with age while DBP decreased, and both remained higher for people from urban than rural areas across the age groups (Figure 4). Kikuyus had higher SBP than Kalenjins, but the differences were less clear for DBP (Table 3). Kikuyus also had higher levels of glucose, cholesterol, BMI and waist circumference but not of WHR. Kikuyus were more likely to be hypertensive, obese or diabetic in all age groups (Figure 5, 6, 7, 8).
Table 2

Means (and standard error) of cardiovascular risk markers, by gender and urban-rural status

 

Urban-rural comparison

 

Men

Women

 

No. Urban/Rural

Urban

Rural

Age adjusted p-value

No. Urban/Rural

Urban

Rural

Age adjusted p-value

Mean SBP

705/1395

143 (24)

140 (24)

<0.0001

726/1550

143 (26)

140 (25)

<0.0001

Mean DBP

705/1395

84 (14)

81 (13)

<0.0001

726/1550

86 (14)

83 (13)

<0.0001

Glucose

692/1373

5.8 (2.9)

4.8 (2.0)

<0.0001

704/1527

5.7 (2.8)

5.1 (2.3)

<0.0001

Cholesterol

698/1342

4.5 (0.9)

4.3 (0.9)

0.0004

718/1514

4.8 (0.9)

4.7 (1.0)

0.08

BMI

700/1385

24 (6)

22 (4)

<0.0001

718/1543

27 (6)

24 (6)

<0.0001

Waist

703/1390

92 (13)

86 (11)

<0.0001

719/1546

96 (13)

89 (13)

<0.0001

WHR

703/1390

0.92 (0.07)

0.92 (0.06)

0.0009

718/1546

0.89 (0.06)

0.89 (0.08)

0.34

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig1_HTML.jpg
Figure 1

Age trends in obesity by urban status.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig2_HTML.jpg
Figure 2

Age trends in hypertension by urban status.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig3_HTML.jpg
Figure 3

Age trends in diabetes by urban status.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig4_HTML.jpg
Figure 4

Age trends in systolic and diastolic blood pressure by urban status.

Table 3

Means (and standard error) of cardiovascular risk markers, by gender and ethnicity

 

Kikuyu-Kalenjin comparison

 

Men

Women

 

No. Kikuyu/Kalenjin

Kikuyu

Kalenjin

Age adjusted p-value

No. Kikuyu/Kalenjin

Kikuyu

Kalenjin

Age adjusted p-value

Mean SBP

1218/535

142 (24)

139 (23)

0.007

1531/473

142 (26)

136 (24)

<0.0001

Mean DBP

1218/535

81 (13)

81 (13)

0.85

1531/473

84 (14)

82 (13)

0.02

Glucose

1209/515

5.5 (2.6)

4.4 (1.7)

<0.0001

1516/449

5.5 (2.6)

4.9 (2.0)

<0.0001

Cholesterol

1177/524

4.4 (1.0)

4.2 (0.7)

<0.0001

1496/466

4.8 (1.0)

4.5 (1.0)

<0.0001

BMI

1207/534

23 (5)

21 (4)

<0.0001

1519/469

26 (6)

23 (5)

<0.0001

Waist

1213/535

89 (12)

86 (11)

0.002

1522/470

91 (14)

88 (13)

<0.0001

WHR

1213/535

0.92 (0.07)

0.92 (0.06)

0.24

1521/470

0.88(0.08)

0.90 (0.06)

<0.0001

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig5_HTML.jpg
Figure 5

Age trends in obesity by ethnicity.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig6_HTML.jpg
Figure 6

Age trends in hypertension by ethnicity.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig7_HTML.jpg
Figure 7

Age trends in diabetes by ethnicity.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2458-10-569/MediaObjects/12889_2010_Article_2480_Fig8_HTML.jpg
Figure 8

Age trends in systolic and diastolic blood pressure by ethnicity.

The odds of hypertension was higher in urban than rural groups after adjustment for age and sex (Odds ratio - OR = 1.7, 95% CI = 1.5-1.9) (Table 4). The association was weakened after adjustment for SES markers and for obesity, smoking and alcohol, but not after adjustment for diabetes and cholesterol. In the fully adjusted model the odds of hypertension remained higher among urban compared to rural dwellers (1.3, 1.1-1.5). People in urban areas were also more likely to have diabetes (2.3, 1.8-2.9). The increased odds was reduced after adjustment for socio-demographic variables, though adjustment for other CVD risk markers had less effect. In the fully adjusted model the odds of diabetes was no longer elevated in urban compared to rural participants (1.3, 0.9-1.7). No clear association was apparent between the odds of high cholesterol and urban status. The pattern for the association between obesity and urban residence was similar to that for diabetes.
Table 4

Rural-urban differences in the prevalence of CVD risk markers

 

Urban (n = 1431)

Rural (n = 2945)

Age and sex adjusted OR (95% CI)

Age, sex and socio-demographic adjusted OR (SES score)

Age, sex, BMI, WHR, smoking, alcohol

Age, sex, diabetes, cholesterol, hypertension

Fully adjusted model

Hypertension

812 (57%)

1379 (47%)

1.7 (1.5-1.9)

1.4 (1.2-1.6)

1.4 (1.2-1.6)

1.6 (1.4-1.8)

1.3 (1.1-1.5)

Normotensive

619 (43%)

1566 (53%)

Baseline

Baseline

Baseline

Baseline

Baseline

Diabetic

139 (10.0%)

144 (5.0%)

2.3 (1.8-2.9)

1.3 (1.0-1.7)

2.0 (1.5-2.5)

2.2 (1.7-2.8)

1.3 (0.9-1.7)

Normal

1256 (90.0%)

2756 (95.0%)

Baseline

Baseline

Baseline

Baseline

Baseline

High cholesterol

316 (22%)

588 (21%)

1.2 (1.0-1.4)

0.9 (0.8-1.1)

1.0 (0.9-1.2)

1.1 (0.9-1.3)

0.9 (0.7-1.1)

Normal cholesterol

1100 (78%)

2268 (79%)

Baseline

Baseline

Baseline

Baseline

Baseline

Obese

287 (20%)

280 (10%)

2.3 (1.9-2.8)

1.3 (1.0-1.6)

2.9 (2.3-3.5)

2.2 (1.8-2.7)

1.5 (1.2-1.9)

Not obese

1131 (80%)

2648 (90%)

Baseline

Baseline

Baseline

Baseline

Baseline

The odds of hypertension was higher among Kikuyus compared to Kalenjins (1.6, 1.4-1.8) (Table 5). The association persisted after adjustment for socio-demographic variables and other CVD risk markers (1.4, 1.2-1.7). Similarly, Kikuyus were more likely to have diabetes and high cholesterol, and these associations were not fully explained by adjustment for potential confounders. Kikuyus were more likely to be obese compared to Kalenjin, but not in models adjustment for SES and urban status. For all four risk markers, the biggest change in the association occurred after adjustment for SES and urban status.
Table 5

Kikuyu-Kalenjin differences in the prevalence of CVD risk markers

 

Kikuyus

Kalenjins

Age and sex adjusted OR (95% CI)

Age, sex and socio-demographic adjusted OR (SES score and urban)

Age, sex, BMI, WHR, smoking, alcohol

Age, sex, diabetes, cholesterol, hypertension

Fully adjusted model

Hypertension

1445 (53%)

420 (42%)

1.6 (1.4-1.8)

1.3 (1.1-1.5)

1.5 (1.3-1.8)

1.5 (1.3-1.7)

1.4 (1.2-1.7)

Normotensive

1304 (47%)

588 (58%)

Baseline

Baseline

Baseline

Baseline

Baseline

Diabetic

219 (8%)

24 (2%)

3.4 (2.2-5.3)

2.2 (1.4-3.4)

3.4 (2.2-5.4)

3.3 (2.2-5.2)

2.3 (1.5-3.8)

Normal

2506 (92%)

940 (98%)

Baseline

Baseline

Baseline

Baseline

Baseline

High cholesterol

648 (24%)

142 (14%)

1.8 (1.5-2.2)

1.6 (1.3-2.0)

1.6 (1.3-2.0)

1.7 (1.4-2.1)

1.5 (1.2-1.9)

Normal cholesterol

2025 (76%)

848 (86%)

Baseline

Baseline

Baseline

Baseline

Baseline

Obese

392 (14%)

80 (8%)

1.8 (1.4-2.3)

1.0 (0.8-1.3)

2.0 (1.5-2.7)

1.7 (1.3-2.2)

1.0 (0.7-1.4)

Not obese

2334 (86%)

923 (92%)

Baseline

Baseline

Baseline

Baseline

Baseline

There was no interaction between urban status and ethnicity for these conditions after adjustment for age and sex (data not shown).

There was substantial variation in the prevalence of hypertension (range 17-77% (DEFF = 2.9) diabetes (range = 0-26%; DEFF = 1.8), high cholesterol (range 0-51.2%, DEFF = 4.3) and obesity (range 0-40%, DEFF = 1.8) between clusters. The variation was similar in rural and urban areas and among Kikuyus and Kalenjins.

Few people had 3-4 (4.5%) or 2 (18.5%) risk markers and the vast majority of the population had no (37.0%) or one (40.1%) risk marker (Table 6). Generally rural dwellers and Kalenjins had fewer risk factors than urban dwellers and Kikuyus. There was a greater than expected frequency of people with 3-4 risk markers than would be expected by chance, and to a lesser extent a higher frequency of people with no risk markers, except among Kalenijn. Together, this provides evidence for clustering of risk markers within individuals, which was more apparent among rural versus urban dwellers, and among Kalenjins compared to Kikuyus.
Table 6

Clustering of risk markers by rural-urban status and ethnicity

No. of risk markers*

Total group

Urban

Rural

Kikuyu

Kalenjin

 

Exp**

Obs

O:E

Exp**

Obs

O:E

Exp**

Obs

O:E

Exp**

Obs

O:E

Exp**

Obs

O:E

0

32.0

37.0

116

24.1

30.0

124

36.3

40.4

111

28.3

33.1

117

44.8

47.0

105

1

47.7

40.1

84

47.4

38.6

81

47.1

40.9

87

47.6

40.3

85

44.6

40.8

92

2

17.9

18.5

103

23.8

24.9

104

15.0

15.3

102

20.8

21.3

102

9.9

10.7

108

3-4

2.3

4.5

193

4.4

6.5

148

1.5

3.5

228

3.2

5.2

165

0.7

1.6

233

Χ2 (3 df)

71.6 P < 0.0001

27.0 p < 0.0001

39.3 p < 0.0001

40.3 p < 0.0001

6.2 p = 0.10

*Hypertension, obesity, diabetes and high cholesterol

**Based on random assortment of four risk marker

Among people with hypertension, only 323 (15%) received drug treatment, 38 (2%) received diet treatment and 7 traditional medicine treatment (0.3%) (Table 7). Among those on drug treatment, only 98 (29%) had controlled hypertension. A far higher proportion of people with diabetes were receiving treatment (68%), which included insulin (n = 32), tablets (n = 143) and/or diet control (n = 43). A further 10 received traditional treatment. For both hypertension and diabetes, treatment was more among people living in urban areas, women, older people and those with a higher SES score. Kalenjins were less likely to receive treatment for hypertension than Kikuyus (0.5, 0.3-0.8), but there was no difference for diabetes.
Table 7

Treatment for hypertension and diabetes

 

Hypertension

Diabetes

 

Drug treatment *

No treatment

% untreated

Multivariate adjusted OR (95% CI)***

Treatment**

No treatment

% untreated

Multivariate adjusted OR (95% CI) ***

Number

323

1868

  

196

91

  

Rural

191

621

76%

Baseline

86

59

41%

Baseline

Urban

132

1247

90%

1.6 (1.2-2.1)

110

32

23%

2.0 (1.1-3.8)

Language

        

Kikuyu

232

1213

84%

Baseline

152

69

31%

Baseline

Kalenjin

20

400

95%

0.5 (0.3-0.8)

15

10

40%

0.9 (0.3-2.1)

Other

72

255

78%

1.3 (0.9-1.8)

29

12

29%

0.9 (0.4-2.0)

Age

        

50-59

128

726

85%

Baseline

67

40

37%

Baseline

60-69

107

561

84%

1.7 (1.2-2.3)

74

29

28%

1.9 (1.0-3.5)

70-79

57

357

86%

2.0 (1.4-3.0)

34

12

26%

3.3 (1.4-7.9)

≥80

31

224

88%

2.0 (1.2-3.3)

21

10

32%

2.6 (0.9-7.3)

Male

93

923

91%

Baseline

92

47

34%

Baseline

Female

230

945

80%

3.4 (2.5-4.5)

104

44

30%

1.8 (1.0-3.1)

SES score

        

1 (poorest)

23

456

95%

Baseline

14

11

44%

Baseline

2

39

456

92%

1.4 (0.8-2.3)

19

22

54%

0.7 (0.3-2.1)

3

87

493

85%

2.7 (1.7-4.4)

60

24

29%

2.3 (0.9-5.9)

4 (richest)

169

456

73%

4.7 (2.9-7.7)

102

33

24%

2.2 (0.8-5.8)

Schooling

        

Any

249

1217

83%

1.3 (1.1-1.5)

41

24

37%

1.2 (0.8-1.8)

None

74

651

90%

Baseline

155

67

30%

Baseline

*Treatment for hypertension included drug treatment only

**Treatment for diabetes included insulin, tablets or diet control

*** Adjusted for age, sex, urban/rural, ethnic group, SES score, schooling.

Sensitivity analysis

We assessed the impact of lowering the threshold random blood glucose level for the classification of "diabetes". Lowering the threshold to ≥10 mmol/L added an additional 13 cases to the original 283 cases (revised prevalence 6.9%), for ≥9 mmol/L this was 41 cases (7.5%), for ≥8 mmol/L this was 84 cases (8.5%) and for ≥7 mmol/L this was 180 cases (10.8%). At the least conservative threshold for diabetes (≥7 mmol/L) almost half of cases (42%) were receiving treatment.

Discussion

This large survey in Kenya highlighted the high prevalence of CVD risk markers, particularly in urban areas. SES was a more important mediator of the association between the individual CVD risk markers and urban status than health behavior or other CVD markers. However, the urban-rural differences in hypertension and obesity were not explained fully after adjustment for SES, obesity, smoking, alcohol or other CVD risk markers. The prevalence of CVD risk markers was higher among Kikuyus than among Kalenjins. Again, these associations were not fully explained after adjustment for the possible confounders, including urban status. A high degree of clustering of these risk markers was apparent, both geographically and within individuals. The clustering within individuals was more marked among rural dwellers and Kalenjins, although they had fewer people with risk factors overall, potentially indicating that there were a few early adopters of these multiple risk factors compared to the more well established presence among urban dwellers and Kikuyus. Only 15% of people with hypertensive were receiving treatment, and this was particularly low among poorer people or rural dwellers. In contrast, more than two thirds of people with diabetes were receiving treatment, although this proportion fell if a lower blood glucose threshold was used for diagnosis of diabetes.

The urban-rural differences in CVD risk markers are likely to be explained by differences in health behavior, including diet and physical activity. These urban-rural differences in lifestyle may in turn explain some of the differences in CVD risk markers between Kikuyus and Kalenjins. However, Kikuyu and Kalenjin participants clearly differed in physical characteristics, such as height, weight and waist and hip circumferences, and these may exert metabolic consequences [30], and explain some of the differences in CVD risk markers.

The prevalence of hypertension in men in our survey was generally high compared to other world regions, and exceeded the prevalence in the Established Market Economies and Latin American Countries for the oldest age group [15]. For women in our survey the pattern was more typical to that seen in the sub-Saharan Africa region. Other studies from Africa confirm the higher prevalence of hypertension, diabetes and obesity in urban compared to rural populations [11, 12, 14, 16, 17, 19, 39]. Previous surveys confirm our finding of a higher prevalence of obesity among women compared to men in Africa [1214], and suggest that BMI differences between rural and urban areas drive differences in diabetes prevalence [39]. Few people with hypertension were currently treated in the Nakuru survey, which is consistent with the findings from other African settings [7, 17, 40], while the proportion of people with diabetics receiving treatment was higher than in other surveys [39].

The high prevalence of CVD markers in Nakuru, particularly hypertension, is likely to be of substantial public health importance, as untreated hypertension is an important modifiable risk factor for stroke in Africa [7, 41]. This is compounded by the low proportion of hypertensives receiving treatment in this population, although the situation was better for diabetes. The rise of non communicable diseases are likely to put further pressure on an already overstretch primary health care system [9], and so prevention is important potentially through reducing obesity and salt intake [23, 42, 43]. Further studies investigating means of reducing hypertension in Africa are needed urgently [44].

There were a number of limitations to this study. The study design was a cross-sectional survey, and so we could not take account of the temporal relationship between potential risk markers and outcomes. We measured blood pressure on only one day and so regression to the mean was possible, and one cuff size was used for all participants. The blood glucose measures were obtained from non-fasting blood samples, rather than through use of the oral glucose tolerance test or fasting blood glucose, and this may have underestimated the prevalence of diabetes. Lowering the threshold blood glucose level cut-off for the definition of diabetes increased the prevalence, however, this was not substantial until the level was reduced to >7 mmol/L. We measured smoking and alcohol status, but we did not assess physical activity or diet or other blood markers (e.g. renin), which were potentially important explanatory variables. Although we measured BMI and WHR, it would have been useful to include bioimpedance as a measure of body fat. Classifying people as "Kikuyu" or "Kalenjin" on the basis of their mother tongue may have been over-simplistic. This study also had important strengths. There was a high response rate, and the sample was representative across Nakuru, limiting the impact of selection bias. We included a measure of SES which was previously validated for this area [37]. The measures of blood pressure and anthropometry were assessed by trained medical staff.

Conclusions

The burden of CVD risk markers is high in Kenya, particularly in urban areas. Exploring differences in CVD risk markers between ethnic groups may help us to elucidate the epidemiology of these conditions in Africa.

Abbreviations

BMI: 

Body Mass Index

CHD: 

Coronary heart disease (CHD)

CVD: 

Cardiovascular disease

DBP: 

Diastolic blood pressure

DEFF: 

Design effect

IOV: 

Inter observer variation

MI: 

Myocardial infarction

SBP: 

Systolic blood pressure

SES: 

Socio-economic status

WHR: 

Waist hip ratio.

Declarations

Acknowledgements

This study was funded by a grant from the British Council for Prevention of Blindness and through support from the Fred Hollows Foundation.

Authors’ Affiliations

(1)
London School of Hygiene & Tropical Medicine

References

  1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006, 367 (9524): 1747-1757. 10.1016/S0140-6736(06)68770-9.View ArticlePubMedGoogle Scholar
  2. Jamison DT, Feachem FG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, Rogo KO, (Eds.): Disease and Mortality in Sub-Saharan Africa. 2006, Washington D.C.: World BankGoogle Scholar
  3. Mathers CD, Bernard C, Iburg K, Inoue M, Ma Fat D, Shibuya K, Stein C, Tomijima N: The Global Burden of Disease in 2002: data sources, methods and results. Edited by: World Health Organization. 2003, Geneva: World Health OrganizationGoogle Scholar
  4. Walker AR, Walker BF, Segal I: Some puzzling situations in the onset, occurrence and future of coronary heart disease in developed and developing populations, particularly such in sub-Saharan Africa. J R Soc Promot Health. 2004, 124 (1): 40-46. 10.1177/146642400312400112.View ArticlePubMedGoogle Scholar
  5. Mensah GA: Ischaemic heart disease in Africa. Heart. 2008, 94 (7): 836-843. 10.1136/hrt.2007.136523.View ArticlePubMedGoogle Scholar
  6. Rao C, Lopez AD, Hemed Y: Causes of Death. Disease and Mortality in Sub-Saharan Africa. Edited by: Jamison D, Feachem FG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, Rogo KO. 2006, Washington D.C.: World Bank, 2Google Scholar
  7. Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM, Machibya H, Unwin N, Alberti KG: Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet. 2000, 355 (9216): 1684-1687. 10.1016/S0140-6736(00)02240-6.View ArticlePubMedGoogle Scholar
  8. Mensah GA: Epidemiology of stroke and high blood pressure in Africa. Heart. 2008, 94 (6): 697-705. 10.1136/hrt.2007.127753.View ArticlePubMedGoogle Scholar
  9. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML: Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet. 2008, 372 (9642): 893-901. 10.1016/S0140-6736(08)61399-9.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Omran AR: The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971, 49 (4): 509-538. 10.2307/3349375.View ArticlePubMedGoogle Scholar
  11. van der Sande MA, Bailey R, Faal H, Banya WA, Dolin P, Nyan OA, Ceesay SM, Walraven GE, Johnson GJ, McAdam KP: Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health. 1997, 2 (11): 1039-1048. 10.1046/j.1365-3156.1997.d01-184.x.View ArticlePubMedGoogle Scholar
  12. Kamadjeu RM, Edwards R, Atanga JS, Kiawi EC, Unwin N, Mbanya JC: Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey. BMC Public Health. 2006, 6: 228-10.1186/1471-2458-6-228.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Sodjinou R, Agueh V, Fayomi B, Delisle H: Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Public Health. 2008, 8: 84-10.1186/1471-2458-8-84.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Christensen DL, Eis J, Hansen AW, Larsson MW, Mwaniki DL, Kilonzo B, Tetens I, Boit MK, Kaduka L, Borch-Johnsen K, et al: Obesity and regional fat distribution in Kenyan populations: impact of ethnicity and urbanization. Ann Hum Biol. 2008, 35 (2): 232-249. 10.1080/03014460801949870.View ArticlePubMedGoogle Scholar
  15. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365 (9455): 217-223.View ArticlePubMedGoogle Scholar
  16. Opie LH, Seedat YK: Hypertension in sub-Saharan African populations. Circulation. 2005, 112 (23): 3562-3568. 10.1161/CIRCULATIONAHA.105.539569.View ArticlePubMedGoogle Scholar
  17. Addo J, Smeeth L, Leon DA: Hypertension in sub-Saharan Africa: a systematic review. Hypertension. 2007, 50 (6): 1012-1018. 10.1161/HYPERTENSIONAHA.107.093336.View ArticlePubMedGoogle Scholar
  18. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.View ArticlePubMedGoogle Scholar
  19. Mbewu A, Mbanya JC: Cardiovascular Diseases. Disease and Mortality in Sub-Saharan Africa. Edited by: Jamison D, Feachem FG, Makgoba MW, Bos ER, Baingana FK, Hofman KJ, Rogo KO. 2006, Washington D.C.: World Bank, 2Google Scholar
  20. World Urbanization Prospects: The 2007 Revision Population Dataset. --- Either ISSN or Journal title must be supplied.. [http://esa.un.org/unup/]
  21. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, Sever PS: The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. Bmj. 1990, 300 (6730): 967-972. 10.1136/bmj.300.6730.967.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Unwin N, James P, McLarty D, Machybia H, Nkulila P, Tamin B, Nguluma M, McNally R: Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study. BMC Public Health. 2010, 10: 272-View ArticlePubMedPubMed CentralGoogle Scholar
  23. Brown IJ, Tzoulaki I, Candeias V, Elliott P: Salt intakes around the world: implications for public health. Int J Epidemiol. 2009, 38 (3): 791-813. 10.1093/ije/dyp139.View ArticlePubMedGoogle Scholar
  24. Colin Bell A, Adair LS, Popkin BM: Ethnic differences in the association between body mass index and hypertension. Am J Epidemiol. 2002, 155 (4): 346-353. 10.1093/aje/155.4.346.View ArticlePubMedGoogle Scholar
  25. Agyemang C, Bhopal R: Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectional data. J Hum Hypertens. 2003, 17 (8): 523-534. 10.1038/sj.jhh.1001586.View ArticlePubMedGoogle Scholar
  26. Brown MJ: Hypertension and ethnic group. Bmj. 2006, 332 (7545): 833-836. 10.1136/bmj.332.7545.833.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004, 364 (9438): 937-952. 10.1016/S0140-6736(04)17018-9.View ArticlePubMedGoogle Scholar
  28. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S: Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005, 112 (23): 3554-3561. 10.1161/CIRCULATIONAHA.105.563452.View ArticlePubMedGoogle Scholar
  29. Milne FJ, Veriava Y, James SH, Isaacson C: Aetiology and pathogenesis of malignant hypertension in black South Africans--a review. S Afr Med J. 1989, Suppl: 22-23.PubMedGoogle Scholar
  30. James WP: The epidemiology of obesity: the size of the problem. J Intern Med. 2008, 263 (4): 336-352. 10.1111/j.1365-2796.2008.01922.x.View ArticlePubMedGoogle Scholar
  31. Turner AG, Magnani RJ, Shuaib M: A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) Cluster Survey design. Int J Epidemiol. 1996, 25 (1): 198-203. 10.1093/ije/25.1.198.View ArticlePubMedGoogle Scholar
  32. Accutrend® GC Detailed information. 2010, --- Either ISSN or Journal title must be supplied.. [http://www.diavant.com/diavant/CMSFront.html?pgid=3%2C1%2C4%2C1#catalog.data]
  33. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42 (6): 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.View ArticlePubMedGoogle Scholar
  34. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group Technical Report Series 727. 1985, Geneva: World Health OrganizationGoogle Scholar
  35. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.
  36. World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. 2000, Geneva: World Health OrganizationGoogle Scholar
  37. Kuper H, Polack S, Eusebio C, Mathenge W, Wadud Z, Foster A: A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh. PLoS Med. 2008, 5 (12): e244-10.1371/journal.pmed.0050244.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Ebrahim S, Montaner D, Lawlor DA: Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis. Bmj. 2004, 328 (7444): 861-10.1136/bmj.38034.702836.55.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, Unwin NC: Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg. 2000, 94 (6): 637-644. 10.1016/S0035-9203(00)90216-5.View ArticlePubMedGoogle Scholar
  40. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J, Eastwood JB: Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004, 43 (5): 1017-1022. 10.1161/01.HYP.0000126176.03319.d8.View ArticlePubMedGoogle Scholar
  41. Connor MD, Thorogood M, Casserly B, Dobson C, Warlow CP: Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke. 2004, 35 (3): 627-632. 10.1161/01.STR.0000117096.61838.C7.View ArticlePubMedGoogle Scholar
  42. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, Forrester T, et al: The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997, 87 (2): 160-168. 10.2105/AJPH.87.2.160.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Kerry SM, Emmett L, Micah FB, Martin-Peprah R, Antwi S, Phillips RO, Plange-Rhule J, Eastwood JB, Cappuccio FP: Rural and semi-urban differences in salt intake, and its dietary sources, in Ashanti, West Africa. Ethn Dis. 2005, 15 (1): 33-39.PubMedGoogle Scholar
  44. Unwin N, Setel P, Rashid S, Mugusi F, Mbanya JC, Kitange H, Hayes L, Edwards R, Aspray T, Alberti KG: Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda?. Bull World Health Organ. 2001, 79 (10): 947-953.PubMedPubMed CentralGoogle Scholar
  45. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/10/569/prepub

Copyright

© Mathenge et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement